Bipolar disorder in later life

Aging Health

Volumn 2, Issue 2, 2006, Pages 333-347

  Chen, Peijun ^a   Ahmed, Mohammed Mahboob ^c   Sajatovic, Martha ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c NONE

Author keywords

Antipsychotic; Bipolar disorder; Elderly; Epidemiology; Mania; Medications; Mood stabilizers

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; CLOZAPINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; ETIRACETAM; FLUOXETINE; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LITHIUM SALT; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PHENYLPROPANOLAMINE; PROCAINAMIDE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; THYROXINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; ZIPRASIDONE; ZONISAMIDE;

AGRANULOCYTOSIS; AKATHISIA; AMBULATORY CARE; ATAXIA; BEHAVIOR THERAPY; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; BLOOD DISEASE; BODY WEIGHT DISORDER; BRAIN DISEASE; CEREBELLUM DISEASE; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; DEHYDRATION; DEMOGRAPHY; DIABETES MELLITUS; DISEASE EXACERBATION; DIZZINESS; DROWSINESS; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG HYPERSENSITIVITY; DYSPEPSIA; ELDERLY CARE; ELECTROCONVULSIVE THERAPY; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; GASTROINTESTINAL SYMPTOM; GERONTOPSYCHIATRY; HAIR LOSS; HEADACHE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; HYPERAMMONEMIA; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; HYPONATREMIA; HYPOTHYROIDISM; INSOMNIA; KIDNEY DISEASE; LIVER DISEASE; LIVER TOXICITY; MANIA; MENTAL HEALTH SERVICE; METABOLIC DISORDER; NAUSEA; ORTHOSTATIC HYPOTENSION; PANCREATITIS; PERIPHERAL EDEMA; PREVALENCE; QT PROLONGATION; REVIEW; SEDATION; SICK SINUS SYNDROME; SIDE EFFECT; SOMNOLENCE; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; TREMOR; URINARY FREQUENCY; VOMITING; WEIGHT GAIN; XEROSTOMIA;

EID: 33646573645     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/1745509X.2.2.333     Document Type: Review

References (109)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch. Gen. Psychiatry 62, 593-602 (2005).
2. Weissman MM, Bland RC, Canino GJ et al.: Cross-national epidemiology of major depression and bipolar disorder. J. Am. Med. Assoc. 276, 293-299 (1996).
3. Kessler RC, McGonagle KA, Zhao S et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 51(1), 8-19 (1994).
4. Regier DA, Boyd JH, Burde JD Jr et al.: One-month prevalence of mental disorder in the United States, based on five epidemiologic catchment area sites. Arch. Gen. Pychiatry 45, 977-986 (1988).
5. Regier DA, Myers JK, Kramer M et al.: The NIMH Epidemiologic Catchment Area program: historical context, major objectives, and study population characteristics. Arch. Gen. Psychiatry 41, 934-941 (1984).
6. Benazzi F, Akiskal HS: Refining the evaluation of bipolar II: beyond the strict SCID-CV guidelines for hypomania. J. Affect. Disord. 73, 33-39 (2003).
7. Angst J: The emerging epidemiology of hypomania and bipolar II disorder. J. Affect. Disord. 50, 143-151 (1998).
8. Judd LL, Akiskal HS: The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J. Affect. Disord. 73, 123-131 (2003).
9. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller HJ, Hirschfeld RM: Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J. Affect. Disord. 59(Suppl. 1), S5-S30 (2000).
10. Szadoczky E, Papp Z, Vitrai J, Rihmer Z, Fueredi J: The prevalence of major depressive and bipolar disorders in Hungary: results from a national epidemiologic survey. J. Affect. Disord. 50, 153-162 (1998).
11. Depp CA, Jeste DV: Bipolar disorder in older adults: a critical review. Bipolar Disord. 6, 343-367 (2004).
12. Young RC, Gyulai L, Mulsant BH et al.: Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am. J. Geriatr. Psychiatry 12, 342-357 (2004).
13. Sajatovic M. Madhusoodanan S, Coconcea N: Managing bipolar disorder in the elderly: defining the role of the newer agents. Drugs Aging 22(1), 39-54 (2005).
14. Weissman M, Leaf P, Tischler G et al.: Affective disorders in five U.S. communities. Psychol. Med.18, 141-153 (1988).
15. UnutzerJ, Simon G, Pabiniak C, Bond K, Katon W: The treated prevalence of bipolar disorder in a large staff-model HMO. Psychiatr. Serv. 49(7), 1072-1078 (1998).
16. Hirschfeld RM, Calabrese JR, Weissman et al.: Screening for bipolar disorder in the community. J. Clin. Psychiatry 64(1), 53-59 (2003).
17. Robins LN, Helzer JE, Croughan JL, Ratcliff KS: National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics and validity. Arch. Gen. Psychiatry 38, 381-389 (1981).
18. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Association, Washington, DC, USA (1994).
19. Robins LN, Wing J, Wittchen H-U et al.: The Composite International Diagnostic Interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch. Gen. Psychiatry 45, 1069-1077 (1988).
20. Morgan VA, Mitchell PB, Jablensky AV: The epidemiology of bipolar disorder: sociodemographic, disability and service utilization data from the Australian National Study of Low Prevalence (Psychotic) Disorders. Bipolar Disord. 7, 326-337 (2005).
21. Meeks S: Bipolar disorder in the latter half of life: symptom presentation, global functioning, and age of onset. J. Affect. Disord. 52, 161-167 (1999).
22. Sajatovic M, Blow FC, Ignacio RV, Kales HC: New-onset bipolar disorder in later life. Am. J. Geriatr. Psychiatry 13(4), 282-289 (2005).
23. Sajatovic M, Popli A, Semple W: Ten-year use of hospital-based services by geriatric veterans with schizophrenia and bipolar disorder. Psychiatr. Serv. 47(9), 961-965 (1996).
24. Bartels SJ, Forester B, Miles KM, Joyce T: Mental health service use by elderly patients with bipolar disorder and unipolar major depression. Am. J. Geriatr. Psychiatry 8(2), 160-166 (2000).
25. Shulman K, Tohen M, Satlin A, Mallya G, Kalunian D: Mania compared with unipolar depression in old age. Am. J. Psychiatry 149, 341-345 (1992).
26. Sajatovic M, Blow C, Ignacio R: Psychiatric comorbidity in older adults with bipolar disorder. Int. J. Geriatr. Psychiatry 21, 1-6 (2006).
27. Cassano GB, McElroy SL, Brady K, Nolen WA, Placidi GF: Current issues in the identification and management of bipolar spectrum disorders in 'special populations'. J. Affect. Disord. 59(Suppl. 1), S69-S79 (2000).
28. Kessing LV: Diagnostic subtypes of bipolar disorder in older versus younger adults. Bipolar Disord. 8, 56-64 (2006).
29. Van Gerpen MW, Johnson JE, Winstead DK: Mania in the geriatric patient population: a review of the literature. Am. J. Geriatr. Psychiatry 7, 188-202 (1999).
30. Goldstein BI, Herrmann N, Shulman KI: Comorbidity in bipolar disorder among the elderly: results from an epidemiological community sample. Am. J. Psychiatry 163(2), 319-321 (2006).
31. Gildengers AG, Mulsant BH, Begley AE et al.: A pilot study of standardized treatment in geriatric bipolar disorder. Am. J. Geriatr. Psychiatry 13(4), 319-323 (2005).
32. Young RC, Murphy CF, Heo M et al.: Cognitive impairment in bipolar disorder in old age: literature review and findings in manic patients. J. Affect. Disord. (2006).
33. Kessing LV, Anderson PK: Does the risk of developing dementla increase with the nubmer of episodes inpatients with depressive disorder and in patients with bipolar disorder? J. Neurol. Neurosurg. Psychiatr. 75(12), 1662-1666 (2004).
34. Krauthammer C, Klerman GL: Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Arch. Gen. Psychiatry 35(11), l333-l339 (1978).
35. Ganzini L, Millar SB, Walsh JR: Drug-induced mania in the elderly. Drugs Aging 3, 428-435 (1993).
36. Sajatovic M: Treatment of bipolar disorder in older adults. Int. J. Geriatr. Psychiatry 17(9), 865-873 (2002).
37. Catterson ML, Preskorn SH, Martin RL: Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology. Psychiatr. Clin. North Am. 20(1), 205-218 (1997).
38. Sunderland T: Neurotransmission in the aging central nervous system. In: Clinical Geriatric Psychopharmacology (4th Edition). Salzman C (Ed). Lippincott Williams & Wilkins, Philadelphia, USA, 63-86 (2005).
39. Abbott FS, Kassam J, Orr JM et al.: The effect of aspirin on valproic acid metabolism. Clin. Pharmacol. Ther. 40, 94-100 (1986).
40. Shulman KI, Rochon P, Suykora K et al.: Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. Br. Med. J. 326(7396), 960-961 (2003).
41. Kessing LV, Sondergard L, Kvist K, Andersen PK: Suicide risk in patients treated with lithium. Arch. Gen. Psychiatry 62(8), 860-866 (2005).
42. Schaffer CB, Garvey MJ: Use of lithium in acutely manic elderly patients. Clin. Gerontol. 3, 58-60 (1984).
43. Eastham JH, Jeste DV, Young RD: Assessment and treatment of bipolar disorder in the elderly. Drugs Aging 12(3), 205-224 (1998).
44. Shulman KI, Sykora K, Gill SS et al.: New thyroxine treatment in older adults beginning lithium therapy: implications for clinical practice. Am. J. Geriatr. Pychiatry 13(4), 299-304 (2005).
45. Vestergaard P, Rejnmark L, Mosekilde L: Reduced relative risk of fractures among users of lithium. Calcif. Tiss. Int. 77(1), 1-8 (2005).
46. Dunner DL: Safety and tolerability of emerging pharmacological treatment for bipolar disorder. Bipolar Disord. 7, 307-325 (2005).
47. Grunze H, Langosch J, Born C, Schaub G, Walden J: Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design. J. Clin. Psychiatry 64, 781-784 (2003).
48. Kanba S, Yagi G, Kamijima K et al.: The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. Prog. Neuropsychopharmacol. Biol. Psychiatry 18, 707-715 (1994).
49. Kushner SF, Khan A, Lane R, Olson WH: Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. Bipolar Disord. 8, 15-27 (2006).
50. Bowden CL, Lawson DM, Cunningham M et al.: The role of divalproex in the treatment of bipolar disorder. Psychiatry Ann. 32(12), 742-750 (2002).
51. Chen ST, Altshuler LL, Melnyk KA, Erhart SM, Miller E, Mintz J: Efficacy of lithium vs. valproate in the treatment of mania in the elderly: a retrospective study. J. Clin. Psychiatry 60(3), 181-186 (1999).
52. Depakote tablet product information: divalproex sodium delayed-release tablets. Abbott Laboratories, Abbott Park, IL, USA (2001).
53. Rendell JM, Juszczak E, Hainsworth J et al.: Developing the BALANCE trial - the role of the pilot study and start-up phase. Bipolar Disord. 6(1), 26-31 (2004).
54. Geddes JR, Goodwin GM, Rendell JM, Hainsworth J, Van der Gucht E, Young H: New trial should clarify lithium use in bipolar disorder. Br. Med. J. 325, 441 (2002).
55. Young RC, Beyer J, Gyulai et al.: A randomized, controlled trial of acute treatments in late-life mania. International Congress Bipolar Disorder (New Research). June 16-18, Pittsburgh, PA, USA, 270 (2005).
56. Okuma T, Yamashita I, Takahashi R et al.: Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. Pharmacopsychiatry 23(3), 143-150 (1990).
57. Greil W, Kleindienst N, Erazo, N. Muller-Oerlinghausen B: Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J. Clin. Psychopharm. 18(6), 455-460 (1998).
58. Evans DL, Byerly MJ, Greer RA: Secondary mania: diagnosis and treatment. J. Clin. Psychiatry 53(Suppl.), 55-59 (1995).
59. Cates M, Powers R: Concomitant risk and blood dyscrasia in geriatric psychiatry patients treated with carbamazepine. Ann. Pharmacother. 32, 884-887 (1998).
60. Battino D, Corci D, Rossini A et al.: Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data. Epilepsia 44, 923-920 (2003).
61. Leppik JE: Issues in the treatment of epilepsy. Epilepsia 42(Suppl. 4), S1-S6 (2001).
62. Chen PJ, Gong KD, Xu JM, Xu TY, Xia ZY: The efficacy and blood level monitoring of carbamazepine on mania. Chinese J. Neurol. Psychiatry 23(5), 262-269 (1990).
63. Fuller M, Sajatovic M: Drug Information Handbook For Psychiatry (3rd Edition). Lexi-Comp Inc., Cleveland, OH, USA (2002).
64. Calabrese JR, Bowden CL, Sachs G et al.: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J. Clin. Psychiatry 64(9), 1013-1024 (2003).
65. Bowden CL, Calabrese JR, Sachs G et al.: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry 60(4), 392-400 (2003).
66. Sajatovic M, Gyulai L, Calabrese JR et al.: Maintenance treatment outcomes in older patients with bipolar I disorder. Am. J. Geriatr. Psychiatry 13(4), 305-311 (2005).
67. Willmore LJ, Messenheimer JA: Adult experience with lamotrigine. J. Child Neurol. 12(Suppl.), 1-18 (1997).
68. Messenheimer JA: Lamotrigine. Epilepsia 36(Suppl. 2), 87-94 (1995).
69. Lamictal® (lamotrigine) prescribing information. GlaxoSmithKline, NC, USA (2004).
70. Ketter TA, Wang PW, Post RM: Carbamazepine and oxcarbamazepine. In: Textbook of Psychopharmacology. Schatzberg AF, Nemeroff CB (Eds). American Psychiatric Publishing, USA, 581-606 (2004).
71. Yatham LN: Atypical antipsychotics for bipolar disorder. Psychiatr. Clin. North Am. 28, 325-347 (2005).
72. Bayer JL, Siegal A, Kennedy JS et al.: Olanzapine, divalproex and placebo treatment, non-head to head comparisons of older adults acute mania. Institute on Psychiatry Services Annual Meeting. FL, USA (2001).
73. Madhusoodanan S, Brenner R, Alcantra A: Clinical experience with quetiapine in elderly patients with psychotic disorders. J. Geriatr. Psychiatry Neurol. 13(1), 28-32 (2000).
74. Tariot PN, Salzman C, Yeung PP, Pultz J, Rak IW: Long-term use of quetiapine in elderly patients with psychotic disorders. Clin. Ther. 22(9), 1068-1084 (2000).
75. Sajatovic M, Mullen J, Calabrese J: Quetiapine for the treatment of bipolar mania in older adults. International Congress Bipolar Disorder (New Research). June 16-18, Pittsburgh, PA, USA, 209 (2005).
76. Madhusoodanan S, Brenner R, Araujo L, Abaza A: Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J. Clin. Psychiatry 56(11), 514-518 (1995).
77. Madhusoodanan S, Suresh P, Brenner R, Pillai R: Experience with the atypical antipsychotics - risperidone and olanzapine in the elderly. Ann. Clin. Psychiatry 11(3), 113-118 (1999).
78. Schulman RW, Singh A, Shulman KI: Treatment of elderly institutionalized bipolar patients with clozapine. Psychopharmacol. Bull. 33, 113-118 (1997).
79. Meyer JM: A retrospective comparison of weight, lipid and glucose changes between risperidone and olanzapine treated inpatients: metabolic outcomes after one year. J. Clin. Psychiatry 63, 425-433 (2002).
80. American Diabetes Association and American Psychiatric Association: Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27, 596-561 (2004).
81. Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 294, 1934-1943 (2005).
82. US Food and Drug Administration (FDA) Center for Drug Evaluation and Research Public Health Advisory. April 11 (2005).
83. Wang PS, Schneeweiss S, Avorn J et al.: Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N. Engl. J. Med. 353(22), 2335-2341 (2005).
84. SchafferA, Mamdani M, Levitt A, Hermann N: Effect of antidepressant use on admissions to hospital among elderly bipolar patients. Int. J. Geriatr. Psychiatry 21(3), 275-280 (2006).
85. Aizenberg D, Olmer A, Barak Y: Suicide attempts amongst elderly bipolar patients. J. Affect. Disord. 91(1), 91-94 (2006).
86. American Psychiatric Association: Practice Guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry 159(4) (2002).
87. Gao K, Calabrese JR: Newer treatment studies for bipolar depression. Bipolar Disord. 7(Suppl. 5), 13-23 (2005).
88. Frangou S: Advancing the pharmacological treatment of bipolar depression. Adv. Psychiatr. Treat. 11, 28-37 (2005).
89. Dubovsky SL: Treatment of bipolar depression. Psychiatr. Clin. North Am. 28, 349-370 (2005).
90. American Psychiatric Association: The Practice of ECT: Recommendations for Treatment, Training, and Privileging (2nd Edition). American Psychiatric Press, DC, USA (2001).
91. Mukherjee S, Sackeim HA, Schnur DB: Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am. J. Psychiatry 151, 169-176 (1994).
92. Grunhaus L, Schreiber S. Dolberg O et al.: Response to ECT in major depression: are there differences between unipolar and bipolar depression? Bipolar Disord. 4(Suppl. 1), 91-93 (2002).
93. Abrams R: Electroconvulsive Therapy (4th Edition). Oxford University Press, NY, USA (2002).
94. Macedo-Soares MB, Moreno RA, Rigonatti SP, Lafer B: Efficacy of electroconvulsive therapy in treatment-resistant bipolar disorder: a case series. J. ECT 21(1), 31-34 (2005).
95. Kho KH: Treatment of rapid cycling bipolar disorder in the acute and maintenance phase with ECT. J. ECT 18(3), 159-161 (2002).
96. Devanand DP, Polanco P, Cruz R et al.: The efficacy of ECT in mixed affective states. J. ECT 16, 32-37 (2000).
97. Van der Wurff FB, Stek ML, Hoogendijk WJ, Beekman AT: The efficacy and safety of ECT in depressed older adults, a literature review. Int. J. Geriatr. Psychiatry 18, 894-904 (2003).
98. Dolenc TJ, Rasmussen KG: The safety of electroconvulsive therapy and lithium in combination: a case series and review of the literature. J. ECT 21(3), 165-170 (2005).
99. Sartorius A, Wolf J, Henn FA: Lithium and ECT - concurrent use still demands attention: three case reports. World J. Biol. Psychiatry 6(2), 121-124 (2005).
100. Kilbourne AM: The burden of general medical conditions in patients with bipolar disorder. Curr. Psychiatry Rep. 7(6), 471-477 (2005).
101. Kupfer DJ: The increasing medical burden in bipolar disorder. JAMA 293, 2528-2530 (2005).
102. Charney DS, Reynolds CF, Lebowitz BL et al.: Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch. Gen. Psychiatry 60(7), 664-672 (2003).
103. Young RC, Peasley-Miklus K, Shulberg HC: Mood rating scales and psychophathology of mania in old age: selected applications and findings. In: Bipolar Disorders in Later Life. Johns Hopkins Press, Baltimore, MD (2006) (In press).
104. Young RC, Falk JR: Age, manic psychophathology and treatment response. Int. J. Geriatr. Psychiatry 4, 73-78 (1989).
105. Young RC, Kiosses D, Murphy DF et al.: Age and ratings of manic psychophathology. American Association of Geriatric Psychiatry Annual Meeting. Baltimore, MD, USA (2004).
106. Calabrese JR, Keck P, MacFadden W et al.: A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry 162(7), 1351-1360 (2005).
107. Tohen M, Calabrese JR, Sach GS et al.: Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am. J. Psychiatry 163(2), 247-256 (2006).
108. Sajatovic M, Kales H: Diagnosis and management of bipolar disorder with comorbid anxiety in the elderly. J. Clin. Psychiatry. 67(Suppl. 1), 21-27 (2006).
109. Sajatovic M, Blow F, Kales H, Valenstein M, Ignacio R, Ganoczy D: Treatment adherence in late-life bipolar disorder. American Association of Geriatric Psychiatry Annual Meeting. San Juan, Puerto Rico (2006).